ClinicalTrials.Veeva

Menu
A

Anchor Medical Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Amlitelimab
Rocatinlimab
Allopurinol
Dotinurad
E2086
TLL018
Centanafadine
Droxidopa
Xanthine
TAK-906

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 17 total trials

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

The primary objective of this trial is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 in participants with gout w...

Enrolling
Gout
Drug: Dotinurad
Other: Placebo

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling
Gout
Drug: Allopurinol
Drug: Dotinurad

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling
Tophaceous Gout
Drug: Allopurinol
Drug: Dotinurad

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of exce...

Enrolling
Narcolepsy
Drug: E2086
Drug: Placebo

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 yea...

Active, not recruiting
Dermatitis Atopic
Drug: Placebo
Drug: Amlitelimab

This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in part...

Enrolling
Anemia
Inflammatory Bowel Disease (IBD)
Drug: DISC-0974
Drug: Placebo

Trial sponsors

Amgen logo
C
Sanofi logo
D
Eisai logo
H
K
Lundbeck logo
M
Otsuka logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems